Biontech stock.
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript Motley Fool - Wed Mar 20, 1:45PM CDT. BNTX earnings call for the period ending December 31, 2023. BNTX : 93.04 (+1.49%) 3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024 Motley Fool - Mon Dec 18, 2023.A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Answering this question will take us one step closer to our new normal. We know that the vaccines now available across the world will protect their recipients from getting sick wit...The average 12-month price target for BioNTech stock right now is $261.95, roughly 25% lower than the current share price. That average is based on Refinitiv's survey of 12 analysts.On today's stock market, BNTX stock dipped 0.4% and closed at 108.05. BNTX Stock: Lower Boosting Levels Expected. The Pfizer -partnered Covid shot is BioNTech's only commercial product. BioNTech's ...
Contact. For any further questions, you can reach us daily from 12:00 to 16:00 CET under +49 6131 9084-1291. Alternatively, you can also send us an email: [email protected]. Go to contact form. Join us on our mission to improve global health by developing the next generation of immunotherapies and vaccines. BioNTech is growing - and this creates ...BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ...
About BioNTech SE. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, …
See the company profile for BioNTech SE (BNTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ...Their BNTX share price targets range from $90.00 to $171.00. On average, they expect the company's stock price to reach $117.25 in the next year. This suggests ...However, the good news is that BioNTech has plenty of cash on hand. As of June 30, the company's cash and cash equivalents came in at 14.2 billion euros ($15.1 billion), compared with 13.9 billion ...
Is BioNTech Stock a Buy? By Jason Hawthorne – Mar 5, 2021 at 7:44AM You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services.
See the company profile for BioNTech SE (BNTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...
A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ...BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0 F: +49 6131 9084-2121 [email protected]. CompanyNASDAQ: BNTX. BioNTech Se. Market Cap. $22B. Today's Change. (-0.44%) -$0.41. Current Price. $92.31. Price as of May 6, 2024, 10:51 a.m. ET. Or is it too …BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently, marking an ...BioNTech (BNTX) to Report Q2 Earnings: What's in the Cards? Why BioNTech Stock Soared 66% in March While the Market Plunged Nasdaq. If You Invested $10,000 in ...
Mar 20, 2024 · The high end of the outlook lagged BioNTech stock analysts' forecast for $3.37 billion, according to FactSet. In response, BioNTech stock dropped to its lowest point since January 2021 ... What happened. Shares of BioNTech ( BNTX 0.20%) rose on Monday, following the release of the biotechnology company's first-quarter financial results. As of 2 p.m. ET, BioNTech's stock price was up ...80.90%. -16.75%. -163.26%. -35.78%. -95.66%. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for BioNTech SE (BNTX). See many years of revenue, expenses and profits or losses.The forecast ranges from a conservative $366.61 to a sky-high $400.65. Our analysts predict BioNTech SE ADR ( BNTX) to change +337.28% by 2045, soaring from $393.66 to an average price of $402.56, potentially reaching $2,066.47. While $393.66 is the low estimate, the potential upside is significant. BioNTech SE ADR ( BNTX) stock is expected to ...May 6, 2024 ... Fiscal discipline is important going forward, notes Hartaj Singh on Moderna (MRNA). He discusses biotech stocks Moderna and Gilead Sciences ...BioNTech (BNTX) to Report Q2 Earnings: What's in the Cards? Why BioNTech Stock Soared 66% in March While the Market Plunged Nasdaq. If You Invested $10,000 in ...Find out all the key statistics for BioNTech SE (BNTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta (5Y ...
Get the latest stock price, news, and insights for BioNTech SE, a German biotech company developing vaccines and cancer therapies. See the bid, ask, volume, …
Business Summary. BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which …Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …Over Q1 2021, BioNTech posted revenue of about $2.5 billion, with Net Margins coming in at a solid 55%. However, despite the strong financials, BioNTech stock trades at just 6x projected 2021 ...May 10, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B Jan 20, 2022 · BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 which remained ... Open. $92.59. Previous Close- YTD Change. -11.69% 12 Month Change. -11.44% Day Range92.42 - 93.20. 52 Wk Range85.21 - 125.83. Volume. 64.12K (10.74% of Avg) 65 … Last Earnings Release. Mar. 20, 2024. Next Ex-Dividend Date. N/A. Last Ex-Dividend Date. Jun. 02, 2022. In depth view into BNTX (BioNTech) stock including the latest price, news, dividend history, earnings information and financials.
Why BioNTech Stock Was Sinking Today. Why Shares of BioNTech Rose Friday. 2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years. Why Shares of BioNTech Slumped Monday.
Mar 20, 2024 · The high end of the outlook lagged BioNTech stock analysts' forecast for $3.37 billion, according to FactSet. In response, BioNTech stock dropped to its lowest point since January 2021 ...
We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer, and infectious diseases and other serious diseases. As immune engineers we have a deep understanding of the underlying mechanisms that enable the immune system to effectively recognize both external threats like infectious diseases and …Their BNTX share price targets range from $90.00 to $171.00. On average, they expect the company's stock price to reach $117.25 in the next year. This suggests ...View BioNTech (BNTX) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the ...Stock Information Stock Quote & Chart Stock Quote & Chart. Change ... BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0. F: +49 6131 9084-2121.BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June …Discover extensive information about BioNTech share price (BNTX) using our intuitive Charts, Technical Analysis, Historical data, BioNTech stock Reports and more.The clinical milestone is in furtherance of BioNTech’s and DualityBio’s strategic objective to advance BNT323/DB-1303 into late-stage ... As concerns over stock market volatility ...Mar 21, 2024 · Analysts have set 12-month price targets for BioNTech, revealing an average target of $145.43, a high estimate of $171.00, and a low estimate of $100.00. This upward trend is evident, with the ... May 6, 2024 ... Fiscal discipline is important going forward, notes Hartaj Singh on Moderna (MRNA). He discusses biotech stocks Moderna and Gilead Sciences ...BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ...BioNTech shares have soared 171.6% year to date through Friday and Pfizer's stock has lost 7.1%, while the S&P 500 SPX, -0.14% has gained 8.6%. Advertisement Read Next
Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Get the latest price, news, and ratings for BioNTech SE ADR (BNTX), a German biotech company developing cancer and covid vaccines. See its fair value …Aug 7, 2023 · BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ... NEW YORK and MAINZ, GERMANY, MAY 26, 2023 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver COVID-19 vaccines to the European Union.. The amended agreement reflects the …Instagram:https://instagram. pa toll paylego builder onlinecompass state pa ussmart game View BioNTech (BNTX) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the ... book of enoch.metanail complex Stock Information. Stock Quote & Chart. Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week Low. Data Provided by Refinitiv. …Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ... nashville on us map BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come. BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses. Interactive chart for BioNTech SE (BNTX) – analyse all of the data with a huge range of indicators.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...